Silver Book Fact

Survival rates of patients ages 65-75 with valve repair and replacement

Fact image

Vassileva C, Mishkel G, McNeely C, et al. Long-Term Survival of Patients Undergoing Mitral Valve Repair and Replacement: A longitudinal analysis of Medicare fee-for-service beneficiaries. Circ. 2013; 127

Reference

Title
Long-Term Survival of Patients Undergoing Mitral Valve Repair and Replacement: A longitudinal analysis of Medicare fee-for-service beneficiaries
Publication
Circ
Publication Date
2013
Authors
Vassileva C, Mishkel G, McNeely C, et al

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • 5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.  
  • In 2010, ~67,500 SAVRs were performed in the U.S.
     
  • The projected economic value of eliminating deaths from stroke is $7.6 trillion.  
  • Effectiveness of an oral pharmacologic agent in preventing venous thrombosis
    An oral pharmacologic agent has been demonstrated to be at least as effective as an injectable anticoagulant in the prevention of venous thrombosis following hip replacement.